Refractive errors and corneal astigmatism are associated with changes in angle kappa and corneal back elevation at the thinnest point in Pentacam. The purpose of this study is to track: The effect of anterior corneal astigmatism treatment on angle kappa and corneal back elevation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Track changes in angle kappa
Timeframe: through study completion, an average of 2 years